<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23515152</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2320-2890</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Biomedical journal</Title><ISOAbbreviation>Biomed J</ISOAbbreviation></Journal><ArticleTitle>Impact of extracorporeal membrane oxygenation support on clinical outcome of pediatric patients with acute cardiopulmonary failure: a single-center experience.</ArticleTitle><Pagination><StartPage>28</StartPage><EndPage>34</EndPage><MedlinePgn>28-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/2319-4170.107161</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Conventional therapy against acute pediatric cardiopulmonary failure (APCPF) caused by a variety of disease entities remains unsatisfactory with extremely high morbidity and mortality. For refractory APCPF, extracorporeal membrane oxygenation (ECMO) is one of the last resorts.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, the in-hospital outcomes of pediatric patients with refractory APCPF receiving ECMO support were reviewed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between August 2006 and May 2011, a single-center cohort study was performed in pediatric patients who required ECMO support due to cardiogenic shock or severe hypoxemia. A total of 22 patients with mean age of 7.0 &#xb1; 6.3 years received ECMO (male = 11; female = 11). The indications included acute fulminant myocarditis (AFM) (n = 6), congenital diaphragmatic hernia (CDH) (n = 3), acute respiratory distress syndrome (ARDS) (n = 6), enterovirus 71 (n = 3), viral sepsis (n = 2), refractory ventricular fibrillation due to long QT syndrome (n = 1), and pulmonary edema with brain herniation (n = 1). Eighteen patients received veno-arterial (VA) mode ECMO, while another four patients undertook the veno-venous (VV) mode. The duration of ECMO use and hospitalization were 6.1 &#xb1; 3.1 and 24.4 &#xb1; 19.4 days, respectively. The survival rate in patients with AFM was 100% (n = 6). Successful ECMO weaning with uneventful discharge from hospital was noted in 14 (63.6%) patients, whereas in-hospital mortality despite successful ECMO weaning occurred in 5 patients (22.7%). Failure in ECMO weaning and in-hospital death was noted in 3 patients (13.6%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ECMO resuscitation is an effective strategy in the clinical setting of APCPF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ying-Jui</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Sheng-Ying</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chi-Di</ForeName><Initials>CD</Initials></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Hsuan-Chang</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chien-Fu</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Chien</LastName><ForeName>Shao-Ju</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>I-Chun</ForeName><Initials>IC</Initials></Author><Author ValidYN="Y"><LastName>Leu</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Cheuk-Kwan</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Sheung-Fat</ForeName><Initials>SF</Initials></Author><Author ValidYN="Y"><LastName>Sheu</LastName><ForeName>Jiunn-Jye</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Hon-Kan</ForeName><Initials>HK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed J</MedlineTA><NlmUniqueID>101599820</NlmUniqueID><ISSNLinking>2319-4170</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006548" MajorTopicYN="N">Hernia, Diaphragmatic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065630" MajorTopicYN="N">Hernias, Diaphragmatic, Congenital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23515152</ArticleId><ArticleId IdType="doi">10.4103/2319-4170.107161</ArticleId><ArticleId IdType="pii">BiomedJ_2013_36_1_28_107161</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>